Both thrombotic and bleeding events were more frequent in the prophylactic dose group (overall, during hospitalization, and during 28-day follow-up), although these differences did not reach statistical significance.
← all excerpts
Prophylactic vs. Intermediate Tinzaparin Dosage for the Thromboprophylaxis of Acutely Ill Medical Patients at High Risk of Venous Thromboembolism.
1
—
—